Chemours (CC)
(Delayed Data from NYSE)
$20.80 USD
+2.11 (11.29%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $20.79 -0.01 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.80 USD
+2.11 (11.29%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $20.79 -0.01 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth B Momentum F VGM
Zacks News
Harmony's (HMY) Earnings Down, Revenues Increase Y/Y in FY22
by Zacks Equity Research
Harmony (HMY) benefits from higher year over year average gold prices despite a decline in production in fiscal 2022.
CF Industries (CF) Shares Up 11% in 3 Months: Here's Why
by Zacks Equity Research
CF Industries (CF) gains on higher average selling prices on lower global supply availability and strong demand.
Ashland (ASH) Shares Up 17% in 6 Months: What's Driving It?
by Zacks Equity Research
Ashland (ASH) benefits from strong demand in its end markets and its pricing actions to counter inflation.
What Makes Albemarle (ALB) Stock a Solid Choice Right Now
by Zacks Equity Research
Albemarle (ALB) gains on higher volumes and prices in its lithium business and actions to boost its global lithium conversion capacity.
Gold Fields (GFI) Reports Higher Revenues and Profits in 1H22
by Zacks Equity Research
Backed by a ramped-up production and a 3% higher gold price, Gold Fields (GFI) delivers a 16% rise in its normalized earnings in the first half of 2022.
Here's Why You Should Invest in Chemours (CC) Stock Now
by Zacks Equity Research
Chemours (CC) gains on strong end-market demand and its cost-reduction and pricing actions.
Reliance Steel (RS) Gains on Demand Strength, Acquisitions
by Zacks Equity Research
Reliance Steel (RS) benefits from strong underlying demand in its major markets, the strength in metals pricing and strategic acquisitions.
Why You Should Add Ingevity (NGVT) Stock to Your Portfolio
by Zacks Equity Research
Ingevity (NGVT) rides on solid demand and higher selling prices in engineered polymers and industrial specialties businesses and its growth actions.
Albemarle (ALB) Shares Pop 50% in 6 Months: What's Driving It?
by Zacks Equity Research
Forecast-topping earnings performance in Q2 and upbeat outlook for 2022 have contributed to the rally in Albemarle's (ALB) shares.
Here's Why Chemours (CC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Chemours (CC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sociedad Quimica (SQM) Q2 Earnings Lag Estimates, Sales Beat
by Zacks Equity Research
Sociedad Quimica (SQM) benefits from a significant increase in lithium prices in the second quarter.
CC or PPG: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CC vs. PPG: Which Stock Is the Better Value Option?
Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Chemours (CC) and Ryerson Holding (RYI) have performed compared to their sector so far this year.
Chemours (CC) Stock Up 25% in 6 Months: What's Driving It?
by Zacks Equity Research
Chemours (CC) gains on healthy demand, strong execution and its cost-reduction and pricing actions.
Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JPME
Should Value Investors Buy Chemours (CC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CC vs. ALB: Which Stock Is the Better Value Option?
by Zacks Equity Research
CC vs. ALB: Which Stock Is the Better Value Option?
Are Basic Materials Stocks Lagging Chemours (CC) This Year?
by Zacks Equity Research
Here is how Chemours (CC) and Silica Holdings (SLCA) have performed compared to their sector so far this year.
Chemours (CC) Earnings and Revenues Top Estimates in Q2
by Zacks Equity Research
Higher prices contribute favorably to Chemours' (CC) top-line growth in the second quarter.
Chemours (CC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 33.10% and 5.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemours (CC) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Chemours' (CC) second-quarter performance is likely to reflect the increasing adoption of Opteon refrigerants and the benefits of cost-cutting measures.
Earnings Preview: LyondellBasell (LYB) Q2 Earnings Expected to Decline
by Zacks Equity Research
LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Chemours (CC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Best Growth Stocks to Buy for June 29th
by Zacks Equity Research
CIB, CC and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 29, 2022.